SKI Market

Indian Indices

Sensex

84,695.54 -345.91
( -0.41%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,388.37 -362.02
(-0.71%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

NGL Fine Chem Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524774

INE887E01022

475.6713592

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NGLFINE

50.51

798.12

EPS(TTM)

Face Value()

Div & Yield %

25.57

0.14

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	359.29	328.97	275.05	318.67	258.18	152.18
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	359.29	328.97	275.05	318.67	258.18	152.18
Other Income	9.76	15.90	7.61	12.64	8.55	3.34
Stock Adjustments	-1.36	12.06	-23.29	22.03	-1.86	5.39
Total Income	367.69	356.93	259.37	353.34	264.87	160.91
EXPENDITURE :
Raw Materials	186.20	169.05	118.84	172.92	102.77	71.46
Power & Fuel Cost	20.48	18.60	15.45	14.47	9.27	9.75
Employee Cost	50.71	41.32	34.25	33.05	27.24	23.81
Other Manufacturing Expenses	53.17	47.44	37.17	41.21	26.49	18.50
Selling & Administrative Expenses	15.33	14.51	11.24	8.56	11.52	7.94
Miscellaneous Expenses	5.47	5.34	6.09	4.57	1.98	5.19
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	331.37	296.27	223.05	274.77	179.27	136.66
Operating Profit	36.33	60.66	36.33	78.56	85.59	24.24
Interest	3.18	1.80	1.83	1.91	2.20	2.62
Gross Profit	33.15	58.86	34.50	76.65	83.39	21.62
Depreciation	9.27	8.15	7.90	7.67	7.39	7.27
Profit Before Tax	23.88	50.71	26.60	68.98	76.00	14.35
Tax	5.34	11.41	7.21	17.15	19.07	4.94
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.41	0.78	-0.73	-0.42	1.46	-1.19
Reported Net Profit	18.13	38.52	20.12	52.25	55.47	10.60
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	-1.49
Adjusted Net Profit	18.13	38.52	20.12	52.25	55.47	12.09
Adjustment below Net Profit	-0.24	-0.15	-0.08	-0.05	-0.14	-0.44
P & L Balance brought forward	257.51	220.22	201.27	150.15	95.91	86.82
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.08	1.08	1.08	1.08	1.08	1.08
P & L Balance carried down	274.31	257.51	220.22	201.27	150.15	95.91
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	35.00	35.00	35.00	35.00	35.00	35.00
Dividend Per Share(Rs)	1.75	1.75	1.75	1.75	1.75	1.75
Earnings Per Share-Unit Curr	29.35	62.35	32.57	84.57	89.79	17.16
Earnings Per Share(Adj)-Unit Curr	29.35	62.35	32.57	84.57	89.79	17.16
Book Value-Unit Curr	452.60	425.39	365.04	334.36	251.62	163.81
Book Value(Adj)-Unit Curr	452.60	425.39	365.04	334.36	251.62	163.81

84,695.54 -345.91 ( -0.41%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,388.37 -362.02 (-0.71%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)